Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.

Luna BM, Nielsen TB, Cheng B, Pantapalangkoor P, Yan J, Boyle-Vavra S, Bruhn KW, Montgomery C, Spellberg B, Daum R.

PLoS One. 2019 Jun 10;14(6):e0217439. doi: 10.1371/journal.pone.0217439. eCollection 2019.

2.

Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.

Luna BM, Ershova K, Yan J, Ulhaq A, Nielsen TB, Hsieh S, Pantapalangkoor P, Vanscoy B, Ambrose P, Rudin S, Hujer K, Bonomo RA, Actis L, Skaar EP, Spellberg B.

J Antimicrob Chemother. 2019 Sep 1;74(9):2631-2639. doi: 10.1093/jac/dkz225.

3.

Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.

Nielsen TB, Pantapalangkoor P, Luna BM, Bruhn KW, Yan J, Dekitani K, Hsieh S, Yeshoua B, Pascual B, Vinogradov E, Hujer KM, Domitrovic TN, Bonomo RA, Russo TA, Lesczcyniecka M, Schneider T, Spellberg B.

J Infect Dis. 2017 Aug 15;216(4):489-501. doi: 10.1093/infdis/jix315.

4.

Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.

Nielsen TB, Pantapalangkoor P, Yan J, Luna BM, Dekitani K, Bruhn K, Tan B, Junus J, Bonomo RA, Schmidt AM, Everson M, Duncanson F, Doherty TM, Lin L, Spellberg B.

MBio. 2017 Aug 22;8(4). pii: e00818-17. doi: 10.1128/mBio.00818-17.

5.

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.

Luna BM, Ulhaq A, Yan J, Pantapalangkoor P, Nielsen TB, Davies BW, Actis LA, Spellberg B.

mSphere. 2017 Apr 26;2(2). pii: e00140-17. doi: 10.1128/mSphere.00140-17. eCollection 2017 Mar-Apr.

6.

Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.

Cheng BL, Nielsen TB, Pantapalangkoor P, Zhao F, Lee JC, Montgomery CP, Luna B, Spellberg B, Daum RS.

Hum Vaccin Immunother. 2017 Jul 3;13(7):1609-1614. doi: 10.1080/21645515.2017.1304334. Epub 2017 Apr 19.

7.

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B.

Clin Microbiol Rev. 2017 Jan;30(1):409-447. Review.

8.

Ly6G-mediated depletion of neutrophils is dependent on macrophages.

Bruhn KW, Dekitani K, Nielsen TB, Pantapalangkoor P, Spellberg B.

Results Immunol. 2015 Dec 21;6:5-7. doi: 10.1016/j.rinim.2015.12.001. eCollection 2016.

9.

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies.

Nielsen TB, Bruhn KW, Pantapalangkoor P, Junus JL, Spellberg B.

BMC Microbiol. 2015 Nov 2;15:252. doi: 10.1186/s12866-015-0580-8.

10.

Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia.

Bruhn KW, Pantapalangkoor P, Nielsen T, Tan B, Junus J, Hujer KM, Wright MS, Bonomo RA, Adams MD, Chen W, Spellberg B.

J Infect Dis. 2015 Apr 15;211(8):1296-305. doi: 10.1093/infdis/jiu593. Epub 2014 Nov 5.

11.

Transferrin iron starvation therapy for lethal bacterial and fungal infections.

Lin L, Pantapalangkoor P, Tan B, Bruhn KW, Ho T, Nielsen T, Skaar EP, Zhang Y, Bai R, Wang A, Doherty TM, Spellberg B.

J Infect Dis. 2014 Jul 15;210(2):254-64. doi: 10.1093/infdis/jiu049. Epub 2014 Jan 19.

12.

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.

Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B.

Vaccine. 2013 Jan 2;31(2):313-8. doi: 10.1016/j.vaccine.2012.11.008. Epub 2012 Nov 12.

13.

Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.

Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A, Montgomery JI, Reilly U, Barbacci EG, Hujer K, Bonomo RA, Fernandez L, Hancock RE, Adams MD, French SW, Buslon VS, Spellberg B.

MBio. 2012 Oct 2;3(5). pii: e00312-12. doi: 10.1128/mBio.00312-12. Print 2012.

14.

Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B.

PLoS One. 2012;7(1):e29446. doi: 10.1371/journal.pone.0029446. Epub 2012 Jan 10.

Supplemental Content

Loading ...
Support Center